Ardent Health (NYSE:ARDT) Releases FY 2026 Earnings Guidance

Ardent Health (NYSE:ARDT) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.900-1.270 for the period, compared to the consensus estimate of 1.400. The company issued revenue guidance of $6.4 billion-$6.7 billion, compared to the consensus revenue estimate of $6.7 billion.

Wall Street Analyst Weigh In

ARDT has been the topic of several recent analyst reports. Leerink Partners set a $16.00 price objective on shares of Ardent Health in a report on Friday, November 14th. Bank of America decreased their price objective on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a report on Thursday, November 13th. Truist Financial decreased their price objective on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, November 14th. KeyCorp lowered Ardent Health from an “overweight” rating to a “sector weight” rating in a report on Monday, November 17th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Ardent Health in a report on Monday, December 29th. Six equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $14.58.

Ardent Health Stock Up 1.9%

ARDT stock traded up $0.18 during midday trading on Wednesday, hitting $9.59. The stock had a trading volume of 368,289 shares, compared to its average volume of 401,276. The business has a 50-day moving average of $8.98 and a two-hundred day moving average of $11.05. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of 6.61, a price-to-earnings-growth ratio of 5.22 and a beta of 0.46. Ardent Health has a 52-week low of $8.07 and a 52-week high of $15.48. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). Ardent Health had a net margin of 3.24% and a return on equity of 19.02%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.63 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, equities research analysts forecast that Ardent Health will post 1.23 earnings per share for the current fiscal year.

More Ardent Health News

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Ardent said it will participate in March investor conferences, which gives management an opportunity to engage with the market and clarify outlook and reserve accounting. Ardent Health to Participate in March Investor Conferences
• Neutral Sentiment: The company published its quarterly press release and investor slide deck — useful primary sources for the quarter’s details and management commentary. Press Release Slide Deck
• Negative Sentiment: Ardent’s FY‑2026 EPS guidance was updated to $0.900–$1.270, well below the street consensus (~$1.40), and revenue guidance of $6.4B–$6.7B is at or slightly below expectations — a clear near‑term earnings risk that helps explain downside pressure on the stock.
• Negative Sentiment: Quarterly results missed estimates: reported EPS $0.32 vs. $0.35 consensus, and revenue $1.61B vs. $1.63B consensus. Those misses reinforce concerns about near‑term profitability and margin trends.
• Negative Sentiment: Multiple law firms (Hagens Berman, Faruqi & Faruqi, Levi & Korsinsky, others) have announced investigations and a filed securities class action tied to a prior disclosure about reserve methodology (the alleged “180‑day cliff” and a reported ~$97M accounting shock). Litigation and potential restatements or reserve revisions materially increase legal/cash‑flow risk and investor uncertainty. Hagens Berman notice
• Negative Sentiment: Several firms are soliciting lead‑plaintiff applications ahead of March 9 deadlines — an indicator the legal campaign is active and could keep volatility and selling pressure elevated in the near term. Lead plaintiff deadline notice

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently made changes to their positions in ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after acquiring an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares during the last quarter. Jane Street Group LLC boosted its stake in Ardent Health by 235.1% during the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after purchasing an additional 40,318 shares during the period. Acadian Asset Management LLC increased its stake in Ardent Health by 574.9% during the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after buying an additional 34,276 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,769 shares during the period.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.